92 related articles for article (PubMed ID: 21702656)
1. Therapeutic vaccination with an EGF-based vaccine in lung cancer: a step in the transition to a chronic disease.
Rodriguez G; Gonzalez G; Crombet T; Lage A
Expert Rev Respir Med; 2011 Jun; 5(3):337-42. PubMed ID: 21702656
[TBL] [Abstract][Full Text] [Related]
2. Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer.
Neninger Vinageras E; de la Torre A; Osorio Rodríguez M; Catalá Ferrer M; Bravo I; Mendoza del Pino M; Abreu Abreu D; Acosta Brooks S; Rives R; del Castillo Carrillo C; González Dueñas M; Viada C; García Verdecia B; Crombet Ramos T; González Marinello G; Lage Dávila A
J Clin Oncol; 2008 Mar; 26(9):1452-8. PubMed ID: 18349395
[TBL] [Abstract][Full Text] [Related]
3. Combining an EGF-based cancer vaccine with chemotherapy in advanced nonsmall cell lung cancer.
Neninger E; Verdecia BG; Crombet T; Viada C; Pereda S; Leonard I; Mazorra Z; Fleites G; González M; Wilkinson B; González G; Lage A
J Immunother; 2009 Jan; 32(1):92-9. PubMed ID: 19307998
[TBL] [Abstract][Full Text] [Related]
4. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T
Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547
[TBL] [Abstract][Full Text] [Related]
5. A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial.
González G; Crombet T; Catalá M; Mirabal V; Hernández JC; González Y; Marinello P; Guillén G; Lage A
Ann Oncol; 1998 Apr; 9(4):431-5. PubMed ID: 9636835
[TBL] [Abstract][Full Text] [Related]
6. Chronic vaccination with a therapeutic EGF-based cancer vaccine: a review of patients receiving long lasting treatment.
Gonzalez G; Crombet T; Lage A
Curr Cancer Drug Targets; 2011 Jan; 11(1):103-10. PubMed ID: 21062240
[TBL] [Abstract][Full Text] [Related]
7. CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer.
Crombet Ramos T; Rodríguez PC; Neninger Vinageras E; Garcia Verdecia B; Lage Davila A
Expert Rev Vaccines; 2015; 14(10):1303-11. PubMed ID: 26295963
[TBL] [Abstract][Full Text] [Related]
8. Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine.
Rodriguez PC; Gonzalez I; Gonzalez A; Avellanet J; Lopez A; Perez R; Lage A; Montero E
Vaccine; 2008 Aug; 26(36):4647-54. PubMed ID: 18640164
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor vaccine in non-small-cell lung cancer.
Gonzalez Marinello GM; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2012 Apr; 12(4):439-45. PubMed ID: 22500681
[TBL] [Abstract][Full Text] [Related]
10. Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.
Labrada M; Clavell M; Bebelagua Y; León Jd; Alonso DF; Gabri MR; Veloso RC; Vérez V; Fernández LE
Expert Opin Biol Ther; 2010 Feb; 10(2):153-62. PubMed ID: 20088712
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic vaccination with epidermal growth factor (EGF) in advanced lung cancer: analysis of pooled data from three clinical trials.
González G; Crombet T; Neninger E; Viada C; Lage A
Hum Vaccin; 2007; 3(1):8-13. PubMed ID: 17204867
[TBL] [Abstract][Full Text] [Related]
12. Treatment of NSCLC patients with an EGF-based cancer vaccine: report of a Phase I trial.
Ramos TC; Vinageras EN; Ferrer MC; Verdecia BG; Rupalé IL; Pérez LM; Marinello GG; Rodríguez RP; Dávila AL
Cancer Biol Ther; 2006 Feb; 5(2):145-9. PubMed ID: 16357522
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.
Nemunaitis J; Dillman RO; Schwarzenberger PO; Senzer N; Cunningham C; Cutler J; Tong A; Kumar P; Pappen B; Hamilton C; DeVol E; Maples PB; Liu L; Chamberlin T; Shawler DL; Fakhrai H
J Clin Oncol; 2006 Oct; 24(29):4721-30. PubMed ID: 16966690
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer.
Xing P; Wang H; Yang S; Han X; Sun Y; Shi Y
BMC Immunol; 2018 Apr; 19(1):14. PubMed ID: 29661145
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates.
Morera Y; Bequet-Romero M; Ayala M; Velazco JC; Pérez PP; Alba JS; Ancizar J; Rodríguez M; Cosme K; Gavilondo JV
Vaccine; 2010 Apr; 28(19):3453-61. PubMed ID: 20197134
[TBL] [Abstract][Full Text] [Related]
16. Effect of an EGF-cancer vaccine on wound healing and inflammation models.
Casacó A; Díaz Y; Ledón N; Merino N; Vadés O; Garcia G; Garcia B; González G; Pérez R
J Surg Res; 2004 Nov; 122(1):130-4. PubMed ID: 15522325
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy induced transient B-cell depletion boosts antibody-forming cells expansion driven by an epidermal growth factor-based cancer vaccine.
Montero E; Valdes M; Avellanet J; Lopez A; Perez R; Lage A
Vaccine; 2009 Apr; 27(16):2230-9. PubMed ID: 19428837
[TBL] [Abstract][Full Text] [Related]
18. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Wong VK; Quagliata R; Adler R; Kim KS
Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
[TBL] [Abstract][Full Text] [Related]
19. Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine.
Conry RM; Allen KO; Lee S; Moore SE; Shaw DR; LoBuglio AF
Clin Cancer Res; 2000 Jan; 6(1):34-41. PubMed ID: 10656429
[TBL] [Abstract][Full Text] [Related]
20. CIMAvax-EGF: Toward long-term survival of advanced NSCLC.
Saavedra D; Neninger E; Rodriguez C; Viada C; Mazorra Z; Lage A; Crombet T
Semin Oncol; 2018 Jan; 45(1-2):34-40. PubMed ID: 30318082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
